Found: 96
Select item for more details and to access through your institution.
Immune therapeutic targeting of glioma cancer stem cells.
- Published in:
- 2010
- By:
- Publication type:
- journal article
FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36430-2
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors for Brain Metastases.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 6, p. 1, doi. 10.1007/s11912-017-0596-3
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors in Gliomas.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 4, p. 1, doi. 10.1007/s11912-017-0586-5
- By:
- Publication type:
- Article
The Eclectic Nature of Glioma-Infiltrating Macrophages and Microglia.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 24, p. 13382, doi. 10.3390/ijms222413382
- By:
- Publication type:
- Article
Myeloid Cell Classification and Therapeutic Opportunities Within the Glioblastoma Tumor Microenvironment in the Single Cell-Omics Era.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.907605
- By:
- Publication type:
- Article
Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment.
- Published in:
- EMBO Journal, 2020, v. 39, n. 15, p. 1, doi. 10.15252/embj.2019103790
- By:
- Publication type:
- Article
Correction to: Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Hypoxia Potentiates Glioma-Mediated Immunosuppression.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0016195
- By:
- Publication type:
- Article
Modulation of Angiogenic and Inflammatory Response in Glioblastoma by Hypoxia.
- Published in:
- PLoS ONE, 2009, v. 4, n. 6, p. 1, doi. 10.1371/journal.pone.0005947
- By:
- Publication type:
- Article
ERK1/2 Phosphorylation Predicts Survival Following anti-pd-1 Immunotherapy in Recurrent Glioblastoma.
- Published in:
- Journal of Neurosurgery, 2022, v. 136, n. 5, p. 130, doi. 10.3171/2022.5.JNS.AANS2022abstracts
- By:
- Publication type:
- Article
Serum microRNA profiling in patients with glioblastoma: a survival analysis.
- Published in:
- Molecular Cancer, 2017, v. 16, p. 1, doi. 10.1186/s12943-017-0628-5
- By:
- Publication type:
- Article
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 983, doi. 10.1007/s00262-013-1405-y
- By:
- Publication type:
- Article
A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 7, p. 1023, doi. 10.1007/s00262-008-0618-y
- By:
- Publication type:
- Article
Topotecan enhances immune clearance of gliomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 259, doi. 10.1007/s00262-008-0550-1
- By:
- Publication type:
- Article
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 123, doi. 10.1007/s00262-007-0336-x
- By:
- Publication type:
- Article
Preferential migration of regulatory T cells mediated by gliomasecreted chemokines can be blocked with chemotherapy.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103<sup>+</sup> dendritic cell differentiation.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-018-08271-x
- By:
- Publication type:
- Article
FGL2 promotes tumor progression in the CNS by suppressing CD103<sup>+</sup> dendritic cell differentiation.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-018-08271-x
- By:
- Publication type:
- Article
The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient Care.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1753, doi. 10.3390/cancers16091753
- By:
- Publication type:
- Article
Targeting Cytokines and Their Pathways for the Treatment of Cancer.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3739, doi. 10.3390/cancers15143739
- By:
- Publication type:
- Article
Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3655, doi. 10.3390/cancers15143655
- By:
- Publication type:
- Article
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1085, doi. 10.3390/cancers15041085
- By:
- Publication type:
- Article
Clinical Management of Supratentorial Non-Skull Base Meningiomas.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5887, doi. 10.3390/cancers14235887
- By:
- Publication type:
- Article
Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5494, doi. 10.3390/cancers14225494
- By:
- Publication type:
- Article
Next Steps for Immunotherapy in Glioblastoma.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 4023, doi. 10.3390/cancers14164023
- By:
- Publication type:
- Article
The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 437, doi. 10.3390/cancers13030437
- By:
- Publication type:
- Article
MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3813, doi. 10.3390/cancers12123813
- By:
- Publication type:
- Article
Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results.
- Published in:
- Acta Neuropathologica Communications, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40478-023-01680-0
- By:
- Publication type:
- Article
Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.682129
- By:
- Publication type:
- Article
Antigen-presenting B cells promote TCF-<sup>1+</sup> PD1<sup>-</sup> stem-like CD<sup>8+</sup> T-cell proliferation in glioblastoma.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2023.1295218
- By:
- Publication type:
- Article
A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 8, p. 1337, doi. 10.1093/neuonc/noab040
- By:
- Publication type:
- Article
Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 356, doi. 10.1093/neuonc/noaa277
- By:
- Publication type:
- Article
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 284, doi. 10.1093/neuonc/noaa182
- By:
- Publication type:
- Article
What is the burden of proof for tumor mutational burden in gliomas?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 17, doi. 10.1093/neuonc/noaa256
- By:
- Publication type:
- Article
Are radiation and response biomarkers the missing elements for efficacious immunotherapy for glioma patients?
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 590, doi. 10.1093/neuonc/noaa018
- By:
- Publication type:
- Article
Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implications.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 2, p. 180, doi. 10.1093/neuonc/noz212
- By:
- Publication type:
- Article
TMIC-33. THE ROLE OF FIBRINOGEN-LIKE PROTEIN 2 ON IMMUNOSUPPRESSION AND MALIGNANT PROGRESSION IN GLIOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi263, doi. 10.1093/neuonc/noy148.1092
- By:
- Publication type:
- Article
TMIC-26. MiR-181a CONTROLS THE OSTEOPONTIN-MEDIATED IMMUNE CIRCUIT IN GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi261, doi. 10.1093/neuonc/noy148.1085
- By:
- Publication type:
- Article
RBTT-07. NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi235, doi. 10.1093/neuonc/noy148.976
- By:
- Publication type:
- Article
RARE-05. TUMOR PROFILING REVEALS EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) AND ENHANCED IMMUNE SUPPRESSION IN GLIOSARCOMAS RELATIVE TO GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi237, doi. 10.1093/neuonc/noy148.983
- By:
- Publication type:
- Article
IMMU-36. IMMUNE RESPONSES IN CANINE GLIOMAS ARE ENRICHED AT THE INFILTRATING EDGE OF ASTROCYTOMAS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi129, doi. 10.1093/neuonc/noy148.539
- By:
- Publication type:
- Article
Comment on "Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma".
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 7, p. 1003, doi. 10.1093/neuonc/noy045
- By:
- Publication type:
- Article
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1047, doi. 10.1093/neuonc/nox026
- By:
- Publication type:
- Article
Immune modulatory nanoparticle therapeutics for intracerebral glioma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 3, p. 372, doi. 10.1093/neuonc/now198
- By:
- Publication type:
- Article
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 10, p. 1357, doi. 10.1093/neuonc/now132
- By:
- Publication type:
- Article
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 5, p. 639, doi. 10.1093/neuonc/nov292
- By:
- Publication type:
- Article
PD-L1 expression and prognostic impact in glioblastoma.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 195, doi. 10.1093/neuonc/nov172
- By:
- Publication type:
- Article